BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Moodys
Baxter
Colorcon
Queensland Health
Deloitte
US Department of Justice
Healthtrust
Dow
Fuji

Generated: January 20, 2018

DrugPatentWatch Database Preview

DOXORUBICIN HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Doxorubicin Hydrochloride patents expire, and when can generic versions of Doxorubicin Hydrochloride launch?

Doxorubicin Hydrochloride is a drug marketed by Actavis Inc, Alvogen Inc, Amneal Pharms Co, Fresenius Kabi Usa, Gland Pharma Ltd, Mylan Labs Ltd, Pharmachemie Bv, Pharmacia And Upjohn, Sagent Pharms, Sandoz Inc, Sun Pharm Inds, Teva Pharms Usa, West-ward Pharms Int, Dr Reddys Labs Ltd, and Sun Pharma Global. and is included in twenty NDAs.

The generic ingredient in DOXORUBICIN HYDROCHLORIDE is doxorubicin hydrochloride. There are seventeen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the doxorubicin hydrochloride profile page.
Drug patent expirations by year for DOXORUBICIN HYDROCHLORIDE
Pharmacology for DOXORUBICIN HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for DOXORUBICIN HYDROCHLORIDE

US Patents and Regulatory Information for DOXORUBICIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 064097-001 Sep 13, 1994 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 062975-001 Mar 17, 1989 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dr Reddys Labs Ltd DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 208657-001 May 15, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 062921-001 Mar 17, 1989 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Inc DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 203622-001 Jun 27, 2014 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 050467-003 May 20, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 200146-001 Jul 18, 2012 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Gland Pharma Ltd DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 209825-001 Aug 11, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharma Global DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 203263-002 Feb 4, 2013 AB RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms Co DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 208888-001 Feb 17, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Queensland Health
Teva
Harvard Business School
Julphar
Federal Trade Commission
US Department of Justice
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot